Hyperinsulinemia alters myoinositol to d-chiroinositol ratio in the follicular fluid of patients with PCOS

Reproductive Sciences

Volumn 21, Issue 7, 2014, Pages 854-858

  Unfer, Vittorio ^a   Carlomagno, Gianfranco ^a   Papaleo, Enrico ^b   Vailati, Simona ^b   Candiani, Massimo ^b   Baillargeon, Jean Patrice ^c  

^a A G Un Co Obstetrics and Gynecology Center   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

embryo quality; fertility; myoinositol; oocyte quality; PCOS

Indexed keywords

DEXTRO INOSITOL; FOLLITROPIN; INOSITOL; INSULIN SENSITIZING AGENT; LUTEINIZING HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MASS FRAGMENTOGRAPHY; MYOINOSITOL TO DEXTRO CHIROINOSITOL RATIO; OVARY FOLLICLE FLUID; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; STEREOISOMERISM; TESTOSTERONE BLOOD LEVEL;

EID: 84904633819     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113518985     Document Type: Article

References (35)

1. Homburg R. Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod. 1996 ; 11 (1). 29-39
2. Ciampelli M, Fulghesu AM, Cucinelli F, et al. Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. Metabolism. 1999 ; 48 (2). 167-172
3. Genazzani AD, Battaglia C, Malavasi B, et al. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2004 ; 81 (1). 114-119
4. Nestler JE, Strauss JF. Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinol Metab Clin North Am. 1991 ; 20 (4). 807-823
5. Marshall JC, Dunaif A. Should all women with PCOS be treated for insulin resistance?. Fertil Steril. 2012 ; 97 (1). 18-22
6. Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril. 2004 ; 82 (4). 893-902
7. Kriplani A, Agarwal N. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome. J Reprod Med. 2004 ; 49 (5). 361-367
8. Bilik D, McEwen LN, Brown MB, et al. Thiazolidinediones and fractures: evidence from translating research into action for diabetes. J Clin Endocrinol Metab. 2010 ; 95 (10). 4560-4565
9. Colmers IN, Bowker SL, Majumdar SR, Johnson JA. Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis. CMAJ. 2012 ; 184 (12). E675 - E683
10. Larner J. D-chiro-inositol - its functional role in insulin action and its deficit in insulin resistance. Int J Exp Diabetes Res. 2002 ; 3 (1). 47-60
11. Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol. 2008 ; 24 (3). 139-144
12. Gerli S, Mignosa M, Di Renzo GC. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2003 ; 7 (6). 151-159
13. Chen GN, Huang FX, Wu XP, Zhao ZF, Duan JP. Chemiluminescence determination of melatonin and some of its derivatives using potassium permanganate and formaldehyde system. Anal Bioanal Chem. 2003 ; 376 (6). 873-878
14. Thomas RM, Nechamen CA, Mazurkiewicz JE, Ulloa-Aguirre A, Dias JA. The adapter protein APPL1 links FSH receptor to inositol 1,4,5-trisphosphate production and is implicated in intracellular Ca(2+) mobilization. Endocrinology. 2011 ; 152 (4). 1691-1701
15. Carlomagno G, Unfer V, Roseff S. The d-chiro-inositol paradox in the ovary. Fertil Steril. 2011 ; 95 (8). 2515-2516
16. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004 ; 81 (1). 19-25
17. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004 ; 19 (1). 41-47
18. Gallois Y, Vol S, Caces E, Balkau B. Distribution of fasting serum insulin measured by enzyme immunoassay in an unselected population of 4,032 individuals. Reference values according to age and sex. D.E.S.I.R. Study Group. Donnees Epidemiologiques sur le Syndrome d'Insulino-Resistance. Diabetes Metab. 1996 ; 22 (6). 427-431
19. D'Anna R, Di Benedetto V, Rizzo P, et al. Myo-inositol may prevent gestational diabetes in PCOS women. Gynecol Endocrinol. 2012 ; 28 (6). 440-442
20. Carlomagno G, De Grazia S, Unfer V, Manna F. Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use. Expert Opin Drug Deliv. 2011 ; 9 (3). 267-271
21. Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999 ; 340 (17). 1314-1320
22. Cheang KI, Baillargeon JP, Essah PA, et al. Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. Metabolism. 2008 ; 57 (10). 1390-1397
23. Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Eur Rev Med Pharmacol Sci. 2011 ; 15 (4). 452-457
24. Papaleo E, Unfer V, Baillargeon JP, et al. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril. 2009 ; 91 (5). 1750-1754
25. Sun TH, Heimark DB, Nguygen T, Nadler JL, Larner J. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. Biochem Biophys Res Commun. 2002 ; 293 (3). 1092-1098
26. Larner J, Craig JW. Urinary myo-inositol-to-chiro-inositol ratios and insulin resistance. Diabetes Care. 1996 ; 19 (1). 76-78
27. Harwood K, Vuguin P, DiMartino-Nardi J. Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth. Horm Res. 2007 ; 68 (5). 209-217
28. Matalliotakis I, Kourtis A, Koukoura O, Panidis D. Polycystic ovary syndrome: etiology and pathogenesis. Arch Gynecol Obstet. 2006 ; 274 (4). 187-197
29. Rice S, Christoforidis N, Gadd C, et al. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Hum Reprod. 2005 ; 20 (2). 373-381
30. Chattopadhayay R, Ganesh A, Samanta J, et al. Effect of follicular fluid oxidative stress on meiotic spindle formation in infertile women with polycystic ovarian syndrome. Gynecol Obstet Invest. 2010 ; 69 (3). 197-202
31. Homburg R, Orvieto R, Bar-Hava I, Ben-Rafael Z. Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome. Hum Reprod. 1996 ; 11 (4). 716-719
32. Isabella R, Raffone E. Does ovary need D-chiro-inositol?. J Ovarian Res. 2012 ; 5 (1). 14
33. Heimark D, McAllister J, Larner J. Decreased myo-inositol to chiro-inositol (m/c) ratios and increased m/c epimerase activity in pcos theca cells demonstrate increased insulin sensitivity compared to controls [published online ahead of print]. Endocr J. 2013 ;:
34. Nestler JE, Jakubowicz DJ, de Vargas AF, et al. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998 ; 83 (6). 2001-2005
35. Chiu TT, Rogers MS, Law EL, Briton-Jones CM, Cheung LP, Haines CJ. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod. 2002 ; 17 (6). 1591-1596